DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 2,008 filers reported holding DANAHER CORPORATION in Q1 2022. The put-call ratio across all filers is 1.38 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $847,381,450 | +6.2% | 3,415,484 | +2.7% | 1.39% | +11.5% |
Q2 2023 | $798,273,693 | +3.8% | 3,326,140 | +9.0% | 1.25% | -4.2% |
Q1 2023 | $769,171,099 | -1.5% | 3,051,781 | +3.7% | 1.30% | -10.3% |
Q4 2022 | $780,918,587 | +2.2% | 2,942,199 | -0.6% | 1.45% | -2.4% |
Q3 2022 | $764,277,000 | +13.2% | 2,958,986 | +11.1% | 1.49% | +17.1% |
Q2 2022 | $675,415,000 | -16.5% | 2,664,149 | -3.4% | 1.27% | +5.3% |
Q1 2022 | $809,025,000 | -13.0% | 2,758,071 | -2.4% | 1.21% | +4.7% |
Q4 2021 | $929,654,000 | +18.2% | 2,825,613 | +9.4% | 1.15% | -0.7% |
Q3 2021 | $786,189,000 | -21.6% | 2,582,411 | -30.9% | 1.16% | -23.3% |
Q2 2021 | $1,003,294,000 | -9.9% | 3,738,616 | -24.4% | 1.51% | -20.5% |
Q1 2021 | $1,113,171,000 | +1.7% | 4,945,667 | +0.4% | 1.90% | -2.1% |
Q4 2020 | $1,094,688,000 | +0.9% | 4,927,918 | -2.2% | 1.94% | -13.3% |
Q3 2020 | $1,084,891,000 | +18.6% | 5,038,278 | -2.6% | 2.24% | +5.2% |
Q2 2020 | $914,504,000 | +44.4% | 5,171,664 | +13.0% | 2.13% | +9.8% |
Q1 2020 | $633,248,000 | -2.4% | 4,575,156 | +8.2% | 1.94% | +17.9% |
Q4 2019 | $648,715,000 | -1.3% | 4,226,699 | -7.1% | 1.65% | -10.7% |
Q3 2019 | $657,316,000 | -1.8% | 4,551,099 | -2.9% | 1.84% | -3.8% |
Q2 2019 | $669,628,000 | -2.6% | 4,685,342 | -10.0% | 1.92% | -1.7% |
Q1 2019 | $687,152,000 | +27.7% | 5,204,942 | -0.3% | 1.95% | +7.8% |
Q4 2018 | $538,248,000 | -5.9% | 5,219,633 | -0.9% | 1.81% | +11.1% |
Q3 2018 | $572,030,000 | +13.6% | 5,264,409 | +3.1% | 1.63% | +5.1% |
Q2 2018 | $503,662,000 | -8.6% | 5,103,999 | -9.3% | 1.55% | -13.0% |
Q1 2018 | $550,951,000 | -1.4% | 5,627,124 | -6.5% | 1.78% | +0.7% |
Q4 2017 | $558,718,000 | +1.8% | 6,019,365 | -5.9% | 1.77% | -2.8% |
Q3 2017 | $548,733,000 | -11.0% | 6,396,979 | -12.5% | 1.82% | -3.4% |
Q2 2017 | $616,617,000 | +3.5% | 7,306,756 | +4.9% | 1.88% | -7.2% |
Q1 2017 | $595,526,000 | +11.3% | 6,962,766 | +1.3% | 2.03% | +6.3% |
Q4 2016 | $534,951,000 | -9.4% | 6,872,456 | -8.8% | 1.91% | -5.9% |
Q3 2016 | $590,601,000 | -11.4% | 7,534,129 | +14.2% | 2.03% | -13.3% |
Q2 2016 | $666,270,000 | +4.6% | 6,596,738 | -1.7% | 2.34% | +6.5% |
Q1 2016 | $636,966,000 | +2.3% | 6,713,777 | +0.1% | 2.20% | +4.1% |
Q4 2015 | $622,863,000 | +3.2% | 6,706,112 | -5.3% | 2.11% | -2.0% |
Q3 2015 | $603,708,000 | -7.9% | 7,084,747 | -7.5% | 2.16% | +1.0% |
Q2 2015 | $655,829,000 | -2.2% | 7,662,463 | -3.0% | 2.14% | +0.0% |
Q1 2015 | $670,347,000 | -4.4% | 7,895,721 | -3.5% | 2.13% | -3.5% |
Q4 2014 | $701,468,000 | +7.3% | 8,184,196 | -4.8% | 2.21% | +5.4% |
Q3 2014 | $653,458,000 | -9.2% | 8,600,385 | -5.9% | 2.10% | -7.3% |
Q2 2014 | $719,925,000 | -3.2% | 9,144,228 | -7.8% | 2.26% | -4.5% |
Q1 2014 | $743,888,000 | -1.4% | 9,918,518 | +1.5% | 2.37% | -3.1% |
Q4 2013 | $754,427,000 | +11.9% | 9,772,375 | +0.5% | 2.45% | +1.6% |
Q3 2013 | $674,282,000 | +21.7% | 9,727,073 | +11.2% | 2.41% | +8.5% |
Q2 2013 | $553,949,000 | – | 8,749,175 | – | 2.22% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
RobecoSam USA, Inc. | 74,961 | $7,572,000 | 9.43% |
Corvid Peak Capital Management, LLC | 250,000 | $25,250,000 | 8.54% |
CORTLAND ASSOCIATES INC/MO | 310,508 | $31,361,000 | 6.88% |
Southpoint Capital Advisors LP | 1,250,000 | $126,250,000 | 6.75% |
GREEN VALLEY INVESTORS LLC | 2,168,594 | $219,027,000 | 6.70% |
DAVIS-REA LTD. | 75,080 | $7,595,000 | 5.39% |
CADINHA & CO LLC | 247,143 | $24,961,000 | 5.35% |
Espalier Global Management LLC | 47,100 | $4,757,000 | 5.25% |
Spears Abacus Advisors LLC | 398,334 | $40,232,000 | 5.10% |
GCA INVESTMENT MANAGEMENT, LLC | 158,064 | $15,964,000 | 5.01% |